Fundies. English
Segment disclosures
Company overviewANGIODYNAMICS INC
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
4 dimension combinations 30 retained observations 11 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Med Device
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ango:MedDeviceMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-01 – 2026-08-31 | 40999000 | USD | 20261008 | Open filing evidence |
| 2025-12-01 – 2026-02-28 | 41141000 | USD | 20260402 | Open filing evidence |
| 2025-06-01 – 2026-02-28 | 125371000 | USD | 20260402 | Open filing evidence |
| 2025-09-01 – 2025-11-30 | 43780000 | USD | 20260106 | Open filing evidence |
| 2025-06-01 – 2025-11-30 | 84230000 | USD | 20260106 | Open filing evidence |
| 2025-06-01 – 2025-08-31 | 40450000 | USD | 20261008 | Open filing evidence |
| 2024-12-01 – 2025-02-28 | 40663000 | USD | 20260402 | Open filing evidence |
| 2024-06-01 – 2025-02-28 | 121477000 | USD | 20260402 | Open filing evidence |
| 2024-09-01 – 2024-11-30 | 41291000 | USD | 20260106 | Open filing evidence |
| 2024-06-01 – 2024-11-30 | 80813000 | USD | 20260106 | Open filing evidence |
| 2024-06-01 – 2024-08-31 | 39522000 | USD | 20251002 | Open filing evidence |
Med Device Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ango:MedDeviceSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-06-01 – 2026-05-31 | 170220000 | USD | 20260714 | Open filing evidence |
| 2024-06-01 – 2025-05-31 | 165845000 | USD | 20260714 | Open filing evidence |
| 2023-06-01 – 2024-05-31 | 197511000 | USD | 20260714 | Open filing evidence |
| 2022-06-01 – 2023-05-31 | 242065000 | USD | 20250718 | Open filing evidence |
Med Tech
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ango:MedTechMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-06-01 – 2026-08-31 | 39916000 | USD | 20261008 | Open filing evidence |
| 2025-12-01 – 2026-02-28 | 37282000 | USD | 20260402 | Open filing evidence |
| 2025-06-01 – 2026-02-28 | 108196000 | USD | 20260402 | Open filing evidence |
| 2025-09-01 – 2025-11-30 | 35653000 | USD | 20260106 | Open filing evidence |
| 2025-06-01 – 2025-11-30 | 70914000 | USD | 20260106 | Open filing evidence |
| 2025-06-01 – 2025-08-31 | 35261000 | USD | 20261008 | Open filing evidence |
| 2024-12-01 – 2025-02-28 | 31341000 | USD | 20260402 | Open filing evidence |
| 2024-06-01 – 2025-02-28 | 90863000 | USD | 20260402 | Open filing evidence |
| 2024-09-01 – 2024-11-30 | 31554000 | USD | 20260106 | Open filing evidence |
| 2024-06-01 – 2024-11-30 | 59523000 | USD | 20260106 | Open filing evidence |
| 2024-06-01 – 2024-08-31 | 27969000 | USD | 20251002 | Open filing evidence |
Med Tech Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=ango:MedTechSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-06-01 – 2026-05-31 | 149954000 | USD | 20260714 | Open filing evidence |
| 2024-06-01 – 2025-05-31 | 126653000 | USD | 20260714 | Open filing evidence |
| 2023-06-01 – 2024-05-31 | 106403000 | USD | 20260714 | Open filing evidence |
| 2022-06-01 – 2023-05-31 | 96687000 | USD | 20250718 | Open filing evidence |